Hospital
County of San Bernardino
County of San Bernardino was paid $232K by Medicaid between Jul 2019 and Jul 2023, across 97 billing codes. Its largest line is 0720, — 23% of everything it billed.
33Billing provider infoCOUNTY OF SAN BERNARDINO
COLTON, CA 92324
COLTON, CA 92324
33aNPI1558410217assigned 01/10/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$232K
24GClaims21,568
24DCodes billed97
24AFirst – last monthJul 2019 – Jul 2023
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#302 of 410
Median peer was paid$6.90M
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 387 | $4K | |
| 2020 | 131 | $559.47 | |
| 2021 | 19,088 | $199K | |
| 2022 | 1,948 | $28K | |
| 2023 | 14 | $345.70 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0720 | 23% | 448 | 340 | $54K | |
| 99499 | 16% | 811 | 544 | $38K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 7.6% | 651 | 430 | $18K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 7.2% | 153 | 150 | $17K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.6% | 1,089 | 1,054 | $15K |
| 59025 | Fetal non-stress test | 3.4% | 699 | 411 | $8K |
| 73110 | 3.4% | 399 | 375 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.3% | 271 | 263 | $8K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 3.3% | 196 | 177 | $8K |
| 76801 | 2.9% | 194 | 155 | $7K | |
| 0510 | 1.9% | 256 | 234 | $4K | |
| 73610 | 1.6% | 234 | 225 | $4K |
85 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 1,271 | $3K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.2% | 12 | $3K |
| 73630 | 1.2% | 177 | $3K | |
| 73130 | 1.2% | 172 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 699 | $2K |
| 99070 | <1% | 533 | $2K | |
| 73080 | <1% | 101 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 93 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 991 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 388 | $1K |
| 86941 | <1% | 214 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 375 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 377 | $1K |
| 99283 | Emergency room visit (moderate) | <1% | 13 | $1K |
| 81001 | <1% | 707 | $840.91 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 626 | $740.49 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 344 | $737.37 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 36 | $687.55 |
| 86850 | <1% | 244 | $670.66 | |
| 84702 | <1% | 98 | $670.43 | |
| 73564 | <1% | 41 | $669.94 | |
| 73090 | <1% | 42 | $658.54 | |
| 80076 | <1% | 196 | $608.59 | |
| 85730 | <1% | 231 | $578.97 | |
| 80074 | <1% | 277 | $571.91 | |
| 73590 | <1% | 27 | $540.80 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 209 | $512.83 |
| 85610 | <1% | 311 | $497.88 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 73 | $483.78 |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 12 | $449.88 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 360 | $436.56 |
| 86900 | <1% | 262 | $432.47 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 109 | $417.01 |
| 86901 | <1% | 264 | $416.38 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12 | $394.08 |
| 85379 | <1% | 75 | $366.89 | |
| 0450 | Emergency room services | <1% | 14 | $345.70 |
| 85384 | <1% | 74 | $343.28 | |
| 86780 | <1% | 355 | $341.02 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 732 | $336.30 |
| 87631 | <1% | 14 | $321.12 | |
| 83615 | <1% | 107 | $311.62 | |
| 85027 | <1% | 277 | $306.88 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 18 | $289.52 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 114 | $269.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 130 | $257.40 |
| 82948 | <1% | 109 | $254.09 | |
| 73140 | <1% | 19 | $236.47 | |
| 82570 | <1% | 257 | $236.24 | |
| 87486 | <1% | 12 | $222.27 | |
| 87581 | <1% | 12 | $222.27 | |
| 73560 | <1% | 14 | $221.13 | |
| 81003 | <1% | 285 | $182.00 | |
| 80061 | Lipid panel | <1% | 581 | $177.27 |
| 84550 | <1% | 82 | $160.15 | |
| 82728 | <1% | 54 | $154.82 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 127 | $138.95 |
| 84439 | <1% | 73 | $122.53 | |
| 86140 | <1% | 53 | $106.32 | |
| 82607 | <1% | 47 | $96.71 | |
| 83721 | <1% | 673 | $86.60 | |
| 29065 | <1% | 16 | $77.00 | |
| 84156 | <1% | 46 | $70.21 | |
| 88142 | <1% | 197 | $58.86 | |
| J3490 | Unclassified drugs | <1% | 86 | $58.10 |
| 87210 | <1% | 32 | $48.54 | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 13 | $41.79 |
| 83540 | <1% | 29 | $35.11 | |
| 81025 | <1% | 14 | $33.99 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 13 | $33.65 |
| 85652 | <1% | 15 | $21.74 | |
| 87340 | <1% | 15 | $20.46 | |
| 83735 | <1% | 48 | $17.51 | |
| 82043 | <1% | 128 | $11.44 | |
| 0270 | <1% | 130 | $10.06 | |
| 87081 | <1% | 13 | $8.40 | |
| 3044F | 0% | 554 | $0.00 | |
| 3074F | 0% | 106 | $0.00 | |
| 1036F | 0% | 166 | $0.00 | |
| 99402 | 0% | 100 | $0.00 | |
| 82274 | 0% | 80 | $0.00 | |
| 3046F | 0% | 15 | $0.00 | |
| 3078F | 0% | 101 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 32 | $0.00 |
| 84100 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETRE, PATRICK (CHIEF EXECUTIVE OFFICER)